Gall Matthew
CIK: 0001816194•Chief Financial Officer
Officer
Primary company: iTeos Therapeutics, Inc. (ITOS)
Gall Matthew is a corporate insider (Chief Financial Officer) at iTeos Therapeutics, Inc. (ITOS) filing SEC Form 4 transactions. 21 transactions across 2 companies, totaling $210,932 in purchases and $232,250 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 240,000 | $20.98 | $5.04M | 240,000 | 5/1/2026 Filed: 5/1/2026 | Filing → | |
| Award | 40,000 | - | - | 40,000 | 5/1/2026 Filed: 5/1/2026 | Filing → | |
| Award | 235,000 | - | - | 235,000 | 11/3/2025 Filed: 11/3/2025 | Filing → | |
iTeos Therapeutics, Inc. ITOS | Disposition | 252,135 | - | - | 0 | 8/29/2025 Filed: 8/29/2025 | Filing → |
iTeos Therapeutics, Inc. ITOS | Disposition | 8,123 | - | - | 0 | 8/29/2025 Filed: 8/29/2025 | Filing → |
iTeos Therapeutics, Inc. ITOS | Disposition | 42,388 | - | - | 0 | 8/29/2025 Filed: 8/29/2025 | Filing → |
iTeos Therapeutics, Inc. ITOS | Disposition | 135,937 | - | - | 0 | 8/29/2025 Filed: 8/29/2025 | Filing → |
iTeos Therapeutics, Inc. ITOS | Disposition | 9,063 | - | - | 0 | 8/29/2025 Filed: 8/29/2025 | Filing → |
iTeos Therapeutics, Inc. ITOS | U | 89,429 | - | - | 0 | 8/29/2025 Filed: 8/29/2025 | Filing → |
iTeos Therapeutics, Inc. ITOS | Award | 145,000 | $7.05 | $1.02M | 145,000 | 3/7/2025 Filed: 3/11/2025 | Filing → |
iTeos Therapeutics, Inc. ITOS | Award | 24,000 | - | - | 89,429 | 3/7/2025 Filed: 3/11/2025 | Filing → |
iTeos Therapeutics, Inc. ITOS | Purchase | 5,000 | $7.73 | $39K | 65,429 | 11/19/2024 Filed: 11/19/2024 | Filing → |
iTeos Therapeutics, Inc. ITOS | Award | 163,200 | - | - | 163,200 | 3/7/2024 Filed: 3/8/2024 | Filing → |
iTeos Therapeutics, Inc. ITOS | Award | 41,000 | $0.00 | $0 | 60,429 | 12/5/2023 Filed: 12/7/2023 | Filing → |
iTeos Therapeutics, Inc. ITOS | Purchase | 5,000 | $8.37 | $42K | 19,429 | 10/12/2023 Filed: 10/12/2023 | Filing → |
iTeos Therapeutics, Inc. ITOS | Award | 130,000 | $0.00 | $0 | 130,000 | 3/9/2023 Filed: 3/10/2023 | Filing → |
iTeos Therapeutics, Inc. ITOS | Award | 85,000 | $0.00 | $0 | 85,000 | 3/11/2022 Filed: 3/14/2022 | Filing → |
iTeos Therapeutics, Inc. ITOS | Sale | 5,000 | $46.45 | $232K | 14,429 | 12/27/2021 Filed: 12/28/2021 | Filing → |
iTeos Therapeutics, Inc. ITOS | Exercise | 14,429 | $0.00 | $0 | 42,388 | 10/11/2021 Filed: 10/12/2021 | Filing → |
iTeos Therapeutics, Inc. ITOS | Exercise | 14,429 | $6.16 | $89K | 19,429 | 10/11/2021 Filed: 10/12/2021 | Filing → |
Type
Award
Shares
240,000
Price
$20.98
Value
$5.04M
Type
Award
Shares
40,000
Price
-
Value
-
Type
Award
Shares
235,000
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
Disposition
Shares
252,135
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
Disposition
Shares
8,123
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
Disposition
Shares
42,388
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
Disposition
Shares
135,937
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
Disposition
Shares
9,063
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
U
Shares
89,429
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
Award
Shares
145,000
Price
$7.05
Value
$1.02M
iTeos Therapeutics, Inc.
ITOS
Type
Award
Shares
24,000
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
Purchase
Shares
5,000
Price
$7.73
Value
$39K
iTeos Therapeutics, Inc.
ITOS
Type
Award
Shares
163,200
Price
-
Value
-
iTeos Therapeutics, Inc.
ITOS
Type
Award
Shares
41,000
Price
$0.00
Value
$0
iTeos Therapeutics, Inc.
ITOS
Type
Purchase
Shares
5,000
Price
$8.37
Value
$42K
iTeos Therapeutics, Inc.
ITOS
Type
Award
Shares
130,000
Price
$0.00
Value
$0
iTeos Therapeutics, Inc.
ITOS
Type
Award
Shares
85,000
Price
$0.00
Value
$0
iTeos Therapeutics, Inc.
ITOS
Type
Sale
Shares
5,000
Price
$46.45
Value
$232K
iTeos Therapeutics, Inc.
ITOS
Type
Exercise
Shares
14,429
Price
$0.00
Value
$0
iTeos Therapeutics, Inc.
ITOS
Type
Exercise
Shares
14,429
Price
$6.16
Value
$89K
AI Agent
Try asking...